Evidence map›Paper›PMID 31204364›Full record

ArticleJournal of epidemiology2020

Alcohol Drinking and Bladder Cancer Risk From a Pooled Analysis of Ten Cohort Studies in Japan.

Hiroyuki Masaoka, Keitaro Matsuo, Isao Oze, Hidemi Ito, Mariko Naito, Keiko Wada, Chisato Nagata, Tomio Nakayama, Yuri Kitamura, Atsuko Sadakane and 9 more

Open access · goldAbstract read
In one paragraph

Article in Journal of epidemiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Sphingolipids and the link between alcohol and cancer.Chemico-biological interactions · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 11 institutions in 2 countries.

Hiroyuki MasaokaDivision of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute.ORCID http://orcid.org/0000-0003-1990-5937
Keitaro MatsuoDivision of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute.ORCID http://orcid.org/0000-0003-1761-6314
Isao OzeDivision of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute.ORCID http://orcid.org/0000-0002-0762-1147
Hidemi ItoDepartment of Epidemiology, Nagoya University Graduate School of Medicine.ORCID http://orcid.org/0000-0002-8023-4581
Mariko NaitoDepartment of Oral Epidemiology, Hiroshima University Graduate School of Biomedical and Health Sciences.
Keiko WadaDepartment of Epidemiology and Preventive Medicine, Gifu University Graduate School of Medicine.ORCID http://orcid.org/0000-0002-5467-8592
Chisato NagataDepartment of Epidemiology and Preventive Medicine, Gifu University Graduate School of Medicine.ORCID http://orcid.org/0000-0002-8911-4260
Tomio NakayamaScreening Assessment and Management Group, Center for Public Health Sciences, National Cancer Center.
Yuri KitamuraDepartment of Social Medicine, Osaka University Graduate School of Medicine.
Atsuko SadakaneDepartment of Epidemiology, Radiation Effects Research Foundation.
Akiko TamakoshiDepartment of Public Health, Hokkaido University Graduate School of Medicine.ORCID http://orcid.org/0000-0002-9761-3879
Ichiro TsujiDivision of Epidemiology, Department of Public Health and Forensic Medicine, Tohoku University Graduate School of Medicine.ORCID http://orcid.org/0000-0001-5626-0184
Yumi SugawaraDivision of Epidemiology, Department of Public Health and Forensic Medicine, Tohoku University Graduate School of Medicine.
Norie SawadaEpidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center.ORCID http://orcid.org/0000-0002-9936-1476
Tetsuya MizoueDepartment of Epidemiology and International Health, International Clinical Research Center, National Center for Global Health and Medicine.
Manami InoueEpidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center.ORCID http://orcid.org/0000-0003-1276-2398
Keitaro TanakaDepartment of Preventive Medicine, Faculty of Medicine, Saga University.
Shoichiro TsuganeEpidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center.ORCID http://orcid.org/0000-0003-4105-2774
Taichi ShimazuEpidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center.ORCID http://orcid.org/0000-0001-6000-9830
Prevention Group · USAichi Cancer Center · JPGifu University · JPTohoku University · JPHiroshima University · JPHokkaido University · JPKyushu University · JPNational Center for Global Health and Medicine · JPRadiation Effects Research Foundation · JPSaga University · JPThe University of Osaka · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe association of alcohol drinking with bladder cancer risk remains unclear in East Asian populations. Aldehyde dehydrogenase 2 (ALDH2) enzyme oxidizes alcohol-metabolized carcinogenic acetaldehyde into acetate. It is well known that the inactive ALDH2 carriers, specific to East Asian populations, have an increased risk of several cancer types because of increased exposure to acetaldehyde after alcohol consumption. The aim of this study was to examine the association between alcohol drinking and bladder cancer risk using data from ten population-based prospective cohort studies in Japan, where approximately 40% of the population has inactive ALDH2 enzyme.

methodsWe analyzed 340,497 Japanese participants with average follow-up of 13.4 years. The association between alcohol drinking and bladder cancer risk was evaluated using Cox regression models within each study, and random-effects models were used to estimate pooled hazard ratios (HRs) with corresponding 95% confidence intervals (CIs).

resultsDuring 4,729,071 person-years, 936 men and 325 women were newly diagnosed with bladder cancer. Our results showed no evidence of significant association between alcohol drinking and bladder cancer risk even among men who consumed alcohol of ≥69 g/week, with HR of 1.02 (95% CI, 0.79-1.33). The null result was observed consistently among women.

conclusionsOur findings do not support an association between alcohol drinking and bladder cancer risk in the Japanese, at least without consideration of the polymorphisms of alcohol-metabolizing enzymes.

Indexed as

AdultAlcohol DehydrogenaseAlcohol DrinkingAldehyde DehydrogenaseAldehyde Dehydrogenase, MitochondrialAsian PeopleFemaleHumansJapanMaleMiddle AgedPolymerase Chain ReactionPolymorphism, GeneticProspective StudiesUrinary Bladder NeoplasmsAlcohol DehydrogenaseAldehyde DehydrogenaseAldehyde Dehydrogenase, MitochondrialALDH2 protein, humanalcohol drinkingbladder cancercohort studyJapanpooled analysis

Identifiers

PMID31204364
PMCPMC7280052
OpenAlexW2951774208

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.